Subscribe Now
Rankings
Magazine
Newsletters
Podcasts
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
rankings
See All Rankings
Fortune 500
Global 500
40 Under 40
GREAT PLACE TO WORK LISTS
Best MBA Programs
Magazine
Newsletters
Podcasts
more
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
SEARCH
SIGN IN
Subscribe Now
James Paton
3 pages
Health
GSK’s new vaccine hire looks beyond COVID in quest for next hit: ‘The potential is there to really make a much better flu vaccine’
BY
James Paton
and
Bloomberg
July 3, 2022
Health
Failure to address a global surplus of COVID vaccines raises the risk of new variants emerging, health experts warn
BY
Josh Wingrove
,
James Paton
, and others
May 11, 2022
Health
U.K. to offer Pfizer COVID vaccine to children ages 5 to 11
BY
James Paton
,
Deirdre Hipwell
, and others
February 16, 2022
Health
Moderna chair says COVID could become flu-like endemic in 2022
BY
James Paton
and
Bloomberg
January 14, 2022
Health
COVID-19 cases surge in schools as U.K. waits to offer vaccines to adolescents
BY
Suzi Ring
,
James Paton
, and others
October 19, 2021
Health
Rich countries’ rush to buy Merck antiviral pill risks leaving poor countries behind in COVID fight—again
BY
James Paton
and
Bloomberg
October 12, 2021
Health
World Health Organization backs first Malaria vaccine for at-risk children
BY
James Paton
,
Joel Leon
, and others
October 6, 2021
Health
Global COVID vaccine program Covax falls short of its distribution target
BY
James Paton
and
Bloomberg
September 8, 2021
Health
Rich countries will soon have over 1 billion COVID vaccine doses they don’t need
BY
James Paton
and
Bloomberg
September 6, 2021
Health
AC Immune shares surge on Alzheimer’s drug trial results
BY
Naomi Kresge
,
James Paton
, and others
August 31, 2021
Health
How COVID-19 came raging back in 2021
BY
James Paton
,
Robert Langreth
, and others
July 27, 2021
International
China is filling the global COVID vaccine shortage left by the U.S. and India
BY
Iain Marlow
,
Sudhi Ranjan Sen
, and others
May 8, 2021
International
AstraZeneca revises vaccine efficacy down to 76% after criticism of U.S. trial data
BY
James Paton
,
Michelle Fay Cortez
, and others
March 25, 2021
Leadership
GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment
BY
James Paton
,
Riley Griffin
, and others
March 24, 2021
Health
University of Oxford finds AstraZeneca vaccine effective on British variant
BY
Eric Pfanner
,
James Paton
, and others
February 5, 2021
Most Popular
Personal Finance
Two business school professors break down the deeper reasons why Starbucks customers were so enraged when the company...
January 25, 2023
BY
H. Sami Karaca
,
Jay L. Zagorsky
, and others
Life
A 45-year-old tech CEO is spending millions a year to be 18 again—even though his doctor admits the results are minimal
January 26, 2023
BY
Alexa Mikhail
Success
Men making good money in the prime of their lives are leaning away from demanding jobs and it could be because they’re...
January 27, 2023
BY
Prarthana Prakash
1 - 15 of 36 results
1
2
3
Next Page